The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
- Conditions
- Intraventricular Hemorrhage
- Interventions
- Procedure: Delayed Cord ClampingProcedure: Umbilical Cord Milking
- Registration Number
- NCT01866982
- Lead Sponsor
- Sharp HealthCare
- Brief Summary
Premature babies can be very sick and have bleeding in the brain. Giving babies more blood before cutting the umbilical cord by delayed cord clamping or umbilical cord milking has been shown to reduce the risk of bleeding in the brain. This may be related to improving perfusion to the brain. However, some studies suggest that delayed cord clamping may not increase hemoglobin or blood volume in babies delivered by cesarean section. Milking the umbilical cord may give more blood in babies delivered by Cesarean Section may improve perfusion and reduce bleeding in the brain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 197
- Singleton or multiples pregnancies in patients admitted for medically indicated delivery or in advanced spontaneous preterm labor with imminent delivery at 23 0/7 - 31 6/7 weeks gestation
- Planned vaginal breech delivery
- Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery)
- Fetal death in utero
- Red cell isoimmunization
- Patients who are incapable of informed consent (unconscious, severely ill, mentally handicapped), or are unwilling to undergo randomization
- Placenta accreta or abruption
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Delayed Cord Clamping Delayed Cord Clamping Delayed clamping of the umbilical cord for 45-60 seconds Umbilical Cord Milking Umbilical Cord Milking Milking the umbilical cord 4 times towards the infants at a speed of 20cm/2 seconds
- Primary Outcome Measures
Name Time Method Superior Vena Cava Flow <12 hours of life
- Secondary Outcome Measures
Name Time Method Use of uterotonic agents up to 1 hour after birth Maternal hemoglobin within 48 hours after delivery Severe intraventricular hemorrhage (grade 3 or 4) up to 24 weeks after birth Phototherapy up to 24 weeks after birth Requirement and length of phototherapy
Delivery Room Interventions 10 minutes of life Neurodevelopmental impairment 18-36 months 18-36 months Necrotizing enterocolitis up to 24 weeks after birth Apgar score <7 at 5 minutes at 5 minutes after birth Number of blood transfusions while in the neonatal intensive care unit up to 24 weeks after birth Ionotropic support up to 24 weeks after birth Requirement and length of ionotropic support
Neonatal intensive care unit (NICU) length of stay up to 24 weeks after birth Polycythemia up to 24 hours of life Peak transcutaneous and/or serum bilirubin concentrations up to 24 weeks after birt Blood pressure in first 2 hours of admission to neonatal intensive care unit 2 hours after birth Neonatal death up to 24 weeks of life Umbilical cord pH < 7.0 up to 30 minutes after birth Intraventricular Hemorrhage detected on Head Ultrasound up to 24 weeks after birth Hemoglobin 4 weeks of life Ventilator time up to 24 weeks after birth
Trial Locations
- Locations (3)
Loma Linda Medical Center
🇺🇸Loma Linda, California, United States
Sharp Mary Birch
🇺🇸San Diego, California, United States
University of California, San Diego
🇺🇸San Diego, California, United States